cylindromatosis 1 antibody | knockout validation | Santa Cruz sc-74435

This is a knockout-validated antibody summary, based on the publication "Importance of Validating Antibodies and Small Compound Inhibitors Using Genetic Knockout Studies-T Cell Receptor-Induced CYLD Phosphorylation by IKKε/TBK1 as a Case Study", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

cylindromatosis 1 antibody | knockout validation | Santa Cruz sc-74435 figure 1
Figure 1. Wild-type (wt) or three different CYLD knockout (ko) Jurkat T cell clones were stimulated with 200 ng/ml PMA and 1µM Ionomycin for the indicated times. From [1].
Antibody information

Mouse monoclonal IgG2a (kappa light chain)

Company: Santa Cruz

Antibody: cylindromatosis 1

Catalog number: sc-74435

Summary: Mouse monoclonal IgG2a (kappa light chain) against the C-terminal 419 amino acids of human cylindromatosis 1. Recommended for detection of cylindromatosis 1 of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence and ELISA.

Validation Method

Western blot

Sample

Wild-type and CYLD knockout Jurkat T cell clones.

Blocking agent

5% milk powder in TBS/0.2% Tween 20 (TBST) for 1 h at room temperature (RT).

Primary incubation

1:500 dilution overnight at 4◦C in 5% milk powder in TBST.

Secondary incubation

HRP-conjugated secondary antibodies (GE healthcare) in 5% milk powder in TBST for 1h at RT.

Detection

Western Lightning ECL detection system (Perkin Elmer Life Sciences) according to the manufacturer’s instructions.

References
  1. Lork M, Kreike M, Staal J, Beyaert R. Importance of Validating Antibodies and Small Compound Inhibitors Using Genetic Knockout Studies-T Cell Receptor-Induced CYLD Phosphorylation by IKK?/TBK1 as a Case Study. Front Cell Dev Biol. 2018;6:40 pubmed publisher